香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生 或因依賴該等內容而引致之任何損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1666） 持續關連交易 續訂物業租賃框架協議 董事會謹此宣佈，由於本公司與集團公司訂立之物業租賃框架協議將於二零二五年十 二月三十一日到期，故訂約雙方於二零二五年十二月三十日續訂該協議，協議期限自 二零二六年一月一日起至二零二八年十二月三十一日止，為期三年，並訂立上述協議 項下截至二零二八年十二月三十一日止三個年度擬進行之持續關連交易年度上限。 集团公司乃本公司之最终控股股东，故根据香港上市规则为本公司之關連人士。因此， 根据香港上市规则第14A章，此次續訂之物業租賃框架協議项下拟进行之交易构成本公 司之持续關連交易。 根據國際財務報告準則第16 號，本集團如以承租人身份訂立租賃交易，應在合併財務 報表中確認使用權資產。本集團以承租人身份訂立的續訂之物業租賃框架協議項下租賃 交易將按香港上市規則第14.04(1)(a) 條規定被視為資產收購。 由於 ...

同仁堂（600085）科技(01666)公布，自2025年12月30日起，杜欣女士获委任为公司第九届董事会的非 执行董事。陈飞先生辞任非执行董事亦于同日起生效。 ...

（於中華人民共和國註冊成立的股份有限公司） （股份代號：1666） 董事名單與其角色及職能 北京同仁堂科技發展股份有限公司 (「 本公司 」)之董事會 (「董事會 」 )成員 載列如下： 執行董事： 張毅（董事長） 張春友（總經理） 溫凱婷 非 執 行董事 ： 杜欣 馮莉 獨立非執行董事： 陳清霞 詹原競 李兆彬 職工董事： 朱東生 1 本公司 設有 四 個董事會委員會，其成員如下： 審核委員會 ： 李兆彬（委員會主席） 陳清霞 詹原競 提名委員會 ： 張春友 陳清霞 詹原競 李兆彬 中國，北京 張毅（委員會主席） 陳清霞 詹原競 薪酬委員會 ： 詹原競（委員會主席） 陳清霞 李兆彬 戰略與規劃委員會： 張毅（委員會主席） 二零二 五年 十 二月 三十 日 2 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部份內容 而產生或因依賴該等內容而引致之任何損失承擔任何責任。 北京同仁堂科技發展股份有限公司（「本公司」）董事（「董事」）會（「董事會」） 欣然宣佈，本公司已於二零二五年十二月三十日（星期二）上午九時三十分假座中華人 民共和國（「中國」）北京市豐台區南三環中路20號舉行股東特別大會（「股東特別大 會」）。本公司日期為二零二五年十二月一日之股東特別大會通告內所載之所有決議案 均獲正式通過。 1 於股東特別大會提呈決議案之投票結果 於股東特別大會上，本公司日期為二零二五年十二月一日之股東特別大會通告所載之決 議案均以投票方式表決。 有關於股東特別大會上所提呈決議案之投票結果如下： | 投票數目（股）及 | | | | 投票股份 | | --- | --- | --- | --- | --- | | 佔總票數百分比 | 普通決議案 | | | 總數 | | 贊成 | | | 反對 | | | 1 | 動議批准及確認本公司與中國北京同仁堂（集團） | | | | | 有限 ...

Core Viewpoint - The recent incident involving Tongrentang's "fake krill oil" has highlighted issues related to the non-compliance of contract manufacturing practices in the consumer industry, prompting the State Administration for Market Regulation to announce the upcoming release of the "Food Contract Manufacturing Supervision and Management Measures" [1][2] Group 1: Regulatory Developments - The State Administration for Market Regulation will soon publish the "Food Contract Manufacturing Supervision and Management Measures," which will include oversight of trademark licensing, franchising, raw material processing, and custom production in food contract manufacturing [1] - The new regulations will clarify the food quality and safety responsibilities of both parties involved in contract manufacturing and improve the relevant regulatory system requirements [1] Group 2: Industry Impact - The "fake krill oil" incident is expected to accelerate the implementation of the aforementioned regulatory measures [2]

Group 1 - The market regulatory authority has responded to the "Antarctic krill oil" incident, highlighting issues related to non-compliance in the entrusted production and processing behaviors of companies [1] - Some companies focus solely on sales profits without ensuring product quality, allowing entrusted manufacturers to produce substandard products [1] - A new "Food Entrusted Production Supervision Management Measures" will be released, which will include supervision of trademark licensing, franchising, and custom production, clarifying the food safety responsibilities of both parties involved [1] Group 2 - The market regulatory authority will guide local departments to strengthen supervision over entrusted production behaviors, such as those seen with Tongrentang's private label processing [1] - A special inspection will be organized to increase the scrutiny of products like krill oil and fish oil, with a focus on cracking down on illegal activities [1] - Tongrentang Group has issued an apology after being implicated in a scandal where the detected content was reported as zero [2]

Core Viewpoint - The article discusses the brand integrity issues faced by Beijing Tongrentang, a historic Chinese medicine brand, due to its extensive licensing and outsourcing practices, which have led to product quality concerns and consumer confusion regarding authenticity [2][5][12]. Group 1: Brand Integrity and Licensing Issues - Beijing Tongrentang has faced backlash after a product, "99% High Purity Antarctic Krill Oil," was found to have no phospholipid content, highlighting the risks associated with its brand licensing strategy [2][3]. - The company has a complex network of over 400 subsidiaries, leading to confusion among consumers about which products are genuinely from the original brand [9]. - The brand's licensing practices have resulted in a proliferation of products under the Tongrentang name, often produced by third-party manufacturers, which has diluted the brand's reputation [5][9]. Group 2: Financial Performance and Market Strategy - Beijing Tongrentang's net profit for 2024 is projected to be 1.526 billion yuan, a decline of 8.54% year-on-year, marking the first negative growth in five years [13]. - The company has attempted to modernize and attract younger consumers through new retail initiatives, but these efforts coexist with traditional practices that may undermine brand trust [12][13]. - The brand's expansion into direct sales of health products has raised concerns about the potential risks associated with this business model, which is often viewed negatively in China [12].

Core Viewpoint - The article discusses the potential risks and implications of the brand expansion strategy employed by Beijing Tongrentang, a well-known traditional Chinese medicine brand, highlighting issues related to product quality and brand integrity due to extensive licensing and outsourcing practices [1][3][10]. Group 1: Brand Integrity and Quality Issues - Beijing Tongrentang issued an apology regarding a product quality issue with its "99% high-purity Antarctic krill oil," which claimed a phospholipid content of 43% but was found to be 0% in actual tests [3][10]. - The brand's licensing model has led to a proliferation of products under the Tongrentang name, many of which are produced by third-party manufacturers, raising concerns about the authenticity and quality of these products [3][4][10]. - The complexity of brand ownership and licensing has resulted in confusion among consumers, as multiple entities within the Tongrentang group produce and sell products under similar names, leading to difficulties in distinguishing genuine products from counterfeit ones [6][7][10]. Group 2: Business Model and Market Strategy - The company has expanded its product offerings significantly, including health supplements and daily necessities, which has been referred to as the "Tongrentang Universe," but this expansion raises questions about brand dilution [3][4][10]. - Beijing Tongrentang Health Pharmaceutical has adopted a direct sales model for its health products, which is often associated with negative perceptions in the market, potentially risking the brand's reputation [10][12]. - The company is facing financial challenges, with a reported net profit of 1.526 billion yuan for 2024, marking an 8.54% decline year-on-year, indicating a need for strategic reevaluation amidst its aggressive expansion efforts [12]. Group 3: Consumer Trust and Brand Management - The article emphasizes the importance of establishing modern corporate governance and a robust authorization system to restore consumer trust in the Tongrentang brand, which has been built over a century [12]. - The dual approach of maintaining traditional practices while attempting to attract younger consumers through innovative strategies reflects the internal contradictions faced by the brand during its rapid expansion [12].

Group 1 - The core activity is a series of public welfare events initiated by Tongrentang Technology Company and Beijing Youth Daily, focusing on integrating traditional Chinese medicine (TCM) culture into rural revitalization efforts [1][21] - The events include winter health consultations and TCM cultural experience activities, aimed at promoting health and wellness through TCM knowledge [1][10] - The activities are designed to be engaging and educational, featuring hands-on experiences such as making traditional Chinese medicine pills and learning about herbal identification [3][5] Group 2 - In the community, TCM lectures cover winter health tips, dietary recommendations, and acupoint massage techniques, helping residents understand TCM practices [12][14] - The events also include interactive experiences, such as creating aromatic bracelets, which enhance community engagement with TCM culture [15] - Health consultations provided by experts from Tongrentang and Beijing University of Chinese Medicine address residents' health concerns, offering personalized advice and treatments [17][19] Group 3 - A separate initiative focuses on children with autism, providing TCM cultural experiences and health consultations tailored to their needs [21][23] - The program includes donations of essential rehabilitation materials and aims to improve the well-being of special needs children through TCM therapies [21][23] - The immersive activities allow participants to experience TCM culture through multiple senses, fostering a deeper appreciation for its benefits [23]

Core Viewpoint - The "Golden Award" annual excellence company selection by Gelonghui highlights companies that excel in both economic performance and social responsibility, particularly focusing on ESG (Environmental, Social, Governance) criteria [1][2]. Group 1: Award Winners - Eight companies received the "Annual ESG Pioneer Award (Small and Medium Market Capitalization)" for their outstanding contributions to promoting ESG principles and sustainable development: - Li Jin Technology (00558.HK) - Lianyi Rong Technology-W (09959.HK) - Mobi Development (00947.HK) - Qingci Games (06633.HK) - Tianlun Gas (01600.HK) - Tongrentang Technology (01666.HK) - Weimob Group (02013.HK) - Zhonghui Group (00382.HK) The ranking is in alphabetical order and does not imply any hierarchy [1]. Group 2: Evaluation Criteria - The selection process for the awards involved quantitative data analysis and evaluation by an expert panel, ensuring a comprehensive assessment of the companies' ESG efforts [1]. - The "Annual ESG Pioneer Award" aims to recognize companies that balance economic efficiency with social responsibility, emphasizing their commitment to high-quality sustainable development [1]. Group 3: Event Overview - Gelonghui hosted an online sharing session titled "Technology Empowerment, Capital Breakthrough" on December 22, where the award winners were announced [1]. - The "Golden Award" aims to create a valuable reference list of listed companies and unicorns, covering all listed companies on major exchanges including the Hong Kong Stock Exchange, Shanghai Stock Exchange, Shenzhen Stock Exchange, New York Stock Exchange, and NASDAQ [2].